Literature DB >> 28540649

Myocarditis: A Clinical Overview.

A L P Caforio1, G Malipiero2, R Marcolongo2, S Iliceto3.   

Abstract

PURPOSE OF REVIEW: In this paper we will review the modern diagnostic approach to patients with clinically suspected myocarditis as well as the treatment modalities and strategy in light of up-to-date clinical experience and scientific evidence. RECENT
FINDINGS: Rapidly expanding evidence suggests that myocardial inflammation is frequently underdiagnosed or overlooked in clinical practice, although new therapeutic options have been validated. Moreover, the available evidence suggests that subclinical cardiac involvement has negative prognostic impact on morbidity and mortality and should be actively investigated and adequately treated. Myocarditis represents a growing challenge for physicians, due to increased referral of patients for endomyocardial biopsy (EMB) or cardiac magnetic resonance (CMR), and requires a highly integrated management by a team of caring physicians.

Entities:  

Keywords:  Immunosuppressive therapy; Myocarditis; Systemic immune-mediated disease

Mesh:

Year:  2017        PMID: 28540649     DOI: 10.1007/s11886-017-0870-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   3.955


  101 in total

Review 1.  Stress-related cardiomyopathy syndromes.

Authors:  Kevin A Bybee; Abhiram Prasad
Journal:  Circulation       Date:  2008-07-22       Impact factor: 29.690

2.  CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis.

Authors:  Marco Francone; Cristina Chimenti; Nicola Galea; Fernanda Scopelliti; Romina Verardo; Roberto Galea; Iacopo Carbone; Carlo Catalano; Francesco Fedele; Andrea Frustaci
Journal:  JACC Cardiovasc Imaging       Date:  2014-02-19

3.  Successful Extracorporeal Membrane Oxygenation in a Patient With Fulminant Lupus Myocarditis.

Authors:  Raúl Castellanos-Moreira; Sebastián Rodríguez-García; Teresa López-Sobrino; Aina Capdevila; Sergio Prieto-González; Gerard Espinosa
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2017-01-25

4.  Myocarditis. A histopathologic definition and classification.

Authors:  H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

5.  Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy.

Authors:  Vikas Suri; Subhash Varma; Kiran Joshi; Pankaj Malhotra; Savita Kumari; Sanjay Jain
Journal:  Rheumatol Int       Date:  2009-08-21       Impact factor: 2.631

6.  Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.

Authors:  Uwe Kühl; Matthias Pauschinger; Peter Lothar Schwimmbeck; Bettina Seeberg; Conny Lober; Michel Noutsias; Wolfgang Poller; Heinz-Peter Schultheiss
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

7.  Predictors of outcome in patients with suspected myocarditis.

Authors:  Ingrid Kindermann; Michael Kindermann; Reinhard Kandolf; Karin Klingel; Burkhard Bültmann; Thomas Müller; Angelika Lindinger; Michael Böhm
Journal:  Circulation       Date:  2008-07-21       Impact factor: 29.690

Review 8.  Emerging pharmacologic targets and treatments for myocarditis.

Authors:  Lionel D Jensen; David J Marchant
Journal:  Pharmacol Ther       Date:  2016-03-20       Impact factor: 12.310

9.  Cardiac involvement in Wegener's granulomatosis resistant to induction therapy.

Authors:  Tomasz Miszalski-Jamka; Wojciech Szczeklik; Barbara Sokołowska; Karol Miszalski-Jamka; Krzysztof Karwat; Gabriel Grządziel; Wojciech Mazur; Dean J Kereiakes; Jacek Musiał
Journal:  Eur Radiol       Date:  2011-07-23       Impact factor: 5.315

10.  Endomyocardial biopsy via the femoral access - still safe and valuable diagnostic tool.

Authors:  Sylwia Sławek; Aleksander Araszkiewicz; Agnieszka Gaczkowska; Justyna Koszarska; Damian Celiński; Marek Grygier; Maciej Lesiak; Stefan Grajek
Journal:  BMC Cardiovasc Disord       Date:  2016-11-15       Impact factor: 2.298

View more
  25 in total

Review 1.  Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?

Authors:  Wengen Chen; Jean Jeudy
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

2.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

Review 3.  Diagnostic and prognostic role of cardiac magnetic resonance in acute myocarditis.

Authors:  Chrysanthos Grigoratos; Gianluca Di Bella; Giovanni Donato Aquaro
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

4.  Tissue-tracking in the assessment of late gadolinium enhancement in myocarditis and myocardial infarction.

Authors:  Sara Doimo; Fabrizio Ricci; Nay Aung; Jackie Cooper; Redha Boubertakh; Mihir M Sanghvi; Gianfranco Sinagra; Steffen E Petersen
Journal:  Magn Reson Imaging       Date:  2020-08-25       Impact factor: 3.130

5.  The Optimal Intervention Time of Bone Marrow Mesenchymal Stem Cells in Ameliorating Cardiac Fibrosis Induced by Viral Myocarditis: A Randomized Controlled Trial in Mice.

Authors:  Tingting Wu; Yuan Xie; Jing Huang; Ping Li; Xuliang Wang; Yaoyao Yan; Tianhe Xia; Lei Li; Feng Zhu; Hao Li; Rongzhou Wu
Journal:  Stem Cells Int       Date:  2017-12-05       Impact factor: 5.443

Review 6.  Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.

Authors:  Lifang Zhao; Zhaoying Fu
Journal:  J Immunol Res       Date:  2018-05-07       Impact factor: 4.818

7.  Myocarditis: An Interleukin-1-Mediated Disease?

Authors:  Giacomo De Luca; Giulio Cavalli; Corrado Campochiaro; Moreno Tresoldi; Lorenzo Dagna
Journal:  Front Immunol       Date:  2018-06-13       Impact factor: 7.561

Review 8.  Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis.

Authors:  Daowen Wang; Sheng Li; Jiangang Jiang; Jiangtao Yan; Chunxia Zhao; Yan Wang; Yexin Ma; Hesong Zeng; Xiaomei Guo; Hong Wang; Jiarong Tang; Houjuan Zuo; Li Lin; Guanglin Cui
Journal:  Sci China Life Sci       Date:  2018-12-03       Impact factor: 6.038

9.  Clinical significance of chronic myocarditis: systematic review and meta-analysis.

Authors:  Keiichi Hirono; Shinya Takarada; Mako Okabe; Nariaki Miyao; Hideyuki Nakaoka; Keijiro Ibuki; Sayaka Ozawa; Hideki Origasa; Fukiko Ichida; Kyoko Imanaka-Yoshida
Journal:  Heart Vessels       Date:  2021-08-07       Impact factor: 2.037

10.  Pancreatitis and myocarditis coexistence due to infection by Coxsackie B1 and B4 viruses.

Authors:  Konstantinos Lampropoulos; George Bazoukis; Athanasios Kolyviras; Gary Tse; Athanasios Saplaouras; Themistoklis Iliopoulos
Journal:  Clin Case Rep       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.